These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. FDA Boxed Warning for Immediate-Release Opioids. Food And Drug Administration Public Health Service U S Department Of Health And Human Services J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):141-5. PubMed ID: 27301692 [TBL] [Abstract][Full Text] [Related]
3. Opioid and Benzodiazepine Coprescribing in the United States Before and After US Food and Drug Administration Boxed Warning. Zhang VS; Olfson M; King M JAMA Psychiatry; 2019 Nov; 76(11):1208-1210. PubMed ID: 31532463 [TBL] [Abstract][Full Text] [Related]
5. Polysubstance abuse: alcohol, opioids and benzodiazepines require coordinated engagement by society, patients, and physicians. Ogbu UC; Lotfipour S; Chakravarthy B West J Emerg Med; 2015 Jan; 16(1):76-9. PubMed ID: 25671013 [TBL] [Abstract][Full Text] [Related]
6. Prescribing of Opioids and Benzodiazepines Among Patients With History of Overdose. Griggs C; Wyatt S; Wally MK; Runyon M; Hsu JR; Seymour RB; Beuhler M; Bosse MJ; Fogg R; Gibbs M; Haas E; Jarrett S; Leas D; Saha A; Schiro S; Watling B; J Addict Med; 2019; 13(5):396-402. PubMed ID: 30844876 [TBL] [Abstract][Full Text] [Related]
7. Prescription opioid misuse and the need to promote medication safety among adolescents. Abraham O; Thakur T; Brown R Res Social Adm Pharm; 2019 Jul; 15(7):841-844. PubMed ID: 30655180 [TBL] [Abstract][Full Text] [Related]
9. The epidemiology of benzodiazepine misuse: A systematic review. Votaw VR; Geyer R; Rieselbach MM; McHugh RK Drug Alcohol Depend; 2019 Jul; 200():95-114. PubMed ID: 31121495 [TBL] [Abstract][Full Text] [Related]
10. Factors associated with benzodiazepine prescribing in community mental health settings. Jessell L; Stanhope V; Manuel JI; Mateu-Gelabert P J Subst Abuse Treat; 2020 Feb; 109():56-60. PubMed ID: 31856952 [TBL] [Abstract][Full Text] [Related]
11. Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics. Jann M; Kennedy WK; Lopez G J Pharm Pract; 2014 Feb; 27(1):5-16. PubMed ID: 24436437 [TBL] [Abstract][Full Text] [Related]
12. [The Pharmacist as Gatekeeper of Prescription Drug Abuse: Return to "Community Scientists"]. Shimane T Yakugaku Zasshi; 2016; 136(1):79-87. PubMed ID: 26725672 [TBL] [Abstract][Full Text] [Related]
13. As opioid overdose deaths reach record highs, call for systematic changes grows louder. ED Manag; 2016 Feb; 28(2):13-9. PubMed ID: 26939351 [TBL] [Abstract][Full Text] [Related]
14. Examining racial/ethnic differences in patterns of benzodiazepine prescription and misuse. Cook B; Creedon T; Wang Y; Lu C; Carson N; Jules P; Lee E; Alegría M Drug Alcohol Depend; 2018 Jun; 187():29-34. PubMed ID: 29626743 [TBL] [Abstract][Full Text] [Related]
15. Trends in intentional abuse or misuse of benzodiazepines and opioid analgesics and the associated mortality reported to poison centers across the United States from 2000 to 2014. Calcaterra SL; Severtson SG; Bau GE; Margolin ZR; Bucher-Bartelson B; Green JL; Dart RC Clin Toxicol (Phila); 2018 Nov; 56(11):1107-1114. PubMed ID: 29609498 [TBL] [Abstract][Full Text] [Related]
18. Measuring the Effectiveness of Benzodiazepine Prescriptions Control in Community Setting Using Prescription Drug Monitoring Program (PDMP). Agrawal R; Verma S; Halappanavar M Community Ment Health J; 2021 Jul; 57(5):920-925. PubMed ID: 32666418 [TBL] [Abstract][Full Text] [Related]
19. Opioids with abuse-deterrent properties: A regulatory and technological overview. Haddox JD J Opioid Manag; 2017; 13(6):397-413. PubMed ID: 29308587 [TBL] [Abstract][Full Text] [Related]
20. Risks Associated with Co-Prescribing Opioids and Benzodiazepines and Delaware's Prescription Drug Monitoring Program. Parhami I; Massey J; Trimzi I; Huckshorn K; Gallucci G Del Med J; 2015 Sep; 87(9):270-4; quizz 281. PubMed ID: 26502682 [No Abstract] [Full Text] [Related] [Next] [New Search]